Royalty Pharma Plc (RPRX) Institutional Ownership and Insiders Activity

Royalty Pharma Plc (RPRX) is widely held by institutional investors, with 4 tracked firms reporting positions valued at approximately $181.89M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Dorsey Asset Management is the largest disclosed holder, reporting approximately $109.21M in RPRX holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Dorsey Asset Management representing the majority of disclosed value.

Recent insider activity includes 23 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.